Analyst firms · BofA Securities · GRPH
BofA Securities GRPH price target and rating history
Graphite Bio Inc. (GRPH) · Health Care
BofA Securities rates Graphite Bio Inc. (GRPH) Underperform with a $2 price target, as of its latest action on Feb 23, 2023. It has published 3 rating actions on GRPH since July 2021, including 0 upgrades and 2 downgrades.
- Current rating
- Underperform
- Price target
- $2
- Median target, all firms
- Too few
- Actions on GRPH
- 3
BofA Securities price target on GRPH
Every BofA Securities rating on GRPH
- Feb 23, 2023
- Jan 18, 2023
- Jul 20, 2021
Questions about BofA Securities and GRPH
- What is BofA Securities's price target for GRPH?
- BofA Securities's latest stated price target for Graphite Bio Inc. (GRPH) is $2, from its action on Feb 23, 2023.
- What is BofA Securities's rating on GRPH?
- BofA Securities rates GRPH Underperform, a bearish rating, as of Feb 23, 2023.
- When did BofA Securities last change its view on GRPH?
- On Feb 23, 2023, BofA Securities downgrades to Underperform from Neutral, price target $3 to $2.
All BofA Securities ratingsGRPH news and filingsEvery analyst firm
From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.